Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Tackling a decline of pharmaceutical success

Tackling a decline of pharmaceutical success


Bart Ellenbroek A Victoria University of Wellington researcher will discuss why pharmaceutical industry success rates are so low and suggest solutions to tackle this crisis at an inaugural professorial lecture next Tuesday.

Professor Bart Ellenbroek, from the School of Psychology, will focus on why the pharmaceutical industry is less successful, in terms of new drug registrations when there has been increasing expenditure on research and development over the last few decades.

“This is particularly evident in the fields of oncology and brain disorders, where success rates of drug development projects have dropped below 10 percent,” says Professor Ellenbroek.

“As a result, many large pharmaceutical companies have completely withdrawn from investing in developing treatments for brain disorders, even though one in three individuals in the Western world will suffer from a brain disorder in their lifetime.”

Professor Ellenbroek is an expert in the field of neuroscience and behavioural pharmacology. He joined Victoria University in 2011, moving from Germany to New Zealand to take up the role of associate professor in the School of Psychology.

His research programme, currently including four PhD students, focuses on why some individuals are more susceptible to developing certain psychiatric disorders, with the aim of improving prevention and treatment of these disorders.

Lecture details:
Crisis? What Crisis?
6pm, Tuesday 23 September
Hunter Council Chamber, Level 2, Hunter Building, Gate 1 or 2, Kelburn Parade, Kelburn Campus
RSVP by Friday 19 September. Phone 04-463 5810 or email rsvp@vuw.ac.nz with ‘Ellenbroek’ in the subject line.


ends

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
GenPro: General Practices Begin Issuing Clause 14 Notices

GenPro has been copied into a rising number of Clause 14 notices issued since the NZNO lodged its Primary Practice Pay Equity Claim against General Practice employers in December 2023.More

SPADA: Screen Industry Unites For Streaming Platform Regulation & Intellectual Property Protections

In an unprecedented international collaboration, representatives of screen producing organisations from around the world have released a joint statement.More

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.